Brief Description
Program Description
The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.
Eligibility
- A PhD, MD or equivalent is required.
- Only one submission per applicant is permitted every calendar year.
- Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
- The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.
- Clinical trials eligible
Award Terms
- $600,000 total, payments received at initiation and completion of project
- Project duration is 24 months
- The proposal milestones are to be completed within the two year award timeline
- Indirect costs not to exceed 10% (included in award total-$60,000 maximum)
- One Principal Investigator allowed; Co-Investigators permitted
- No Cost Extensions are not permitted by contract
Key Dates
- March 1, 2024, ( By midnight on this Date): Application Due (Please do not send before January 1, 2024)
- May 1, 2024: Selection of Awardees
- June 15, 2024: Signed Agreements Due
- July 1, 2024: Award Start Date